Ignite Creation Date:
2025-12-24 @ 7:08 PM
Ignite Modification Date:
2026-01-05 @ 11:47 AM
Study NCT ID:
NCT06538857
Status:
RECRUITING
Last Update Posted:
2025-05-23
First Post:
2024-08-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CEB-01 in Locally Resectable Pancreatic Cancer
Sponsor:
CEBIOTEX
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-08-20
Start Date Type:
ACTUAL
Primary Completion Date:
2028-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-09
Completion Date Type:
ESTIMATED
First Submit Date:
2024-08-01
First Submit QC Date:
None
Study First Post Date:
2024-08-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-20
Last Update Post Date:
2025-05-23
Last Update Post Date Type:
ACTUAL